Month: January 2026
-
CJEU publishes European Parliament’s suit against European Commission’s decision to withdraw SEP Regulation
The Commission “prematurely” brought the legislative procedure to an end without legitimate grounds supported by cogent evidence and arguments for doing so, the EP has alleged.
-
China’s top court grants Novo Nordisk win over key Ozempic patent
China’s Supreme People’s Court has upheld a lower court’s decision recognizing the validity of Novo Nordisk’s compound patent related to semaglutide, which is found in the company’s blockbuster drugs Ozempic, Wegovy, and Rybelsus.
-
UPC Mini-Roundup (1 decision): CoA draws line between invalidity contentions against granted patent vs. amendments; double jeopardy did it again
The Unified Patent Court (UPC) has issued only one publicly accessible decision since our December 29, 2025 Roundup, other than a non-newsworthy withdrawal (yet another case in the Access Advance-Transsion context). This roundup is listed among the 2025 as well as 2026 roundups because New Year’s Day fell mid-week. For hearing lists etc., please check…
-
Munich I Regional Court crashes through 300-mark, sets new record for patent infringement filings in one year
The exact number will become known in the weeks ahead, but it’s already certain to set a new record.
-
Lack of European AI patents: detailed analysis of Europe’s technology gap and digital colonization, and why it’s too late to reverse the trend
Europe lacks natural resources and access to cheap, abundant, and reliable energy. The consequences are uncomfortable for Europeans to see, but it’s better to understand the problem and why it can’t/won’t be solved anymore.